Menu
Moscow, November 17, 2017
Starts at 13:00. The participation is free
VI INTERNATIONAL SYMPOSIUM
CONTROVERSIES IN GLAUCOMA:
THE MAIN DISCOVERIES AND PERSPECTIVES IN DIAGNOSTICS AND TREATMENT
About Symposium

The Symposium “Controversies in Glaucoma” is an annual event aimed to expand and deepen the knowledge of Russian ophthalmologists in diagnosis and treatment of glaucoma, as well as to open a dialogue between Russian and foreign medical specialists on the most difficult and unresolved glaucoma aspects. The interest in glaucoma both in Russia and abroad is related to the fact that glaucoma is the most common cause of irreversible blindness in the world, even despite the existing consensus and the accepted standards for glaucoma diagnosis and monitoring. The presentation of the latest achievements and the exchange of opinions on these issues are very useful both for Russian ophthalmologists and for their foreign colleagues. Every year the Symposium expands its borders and attracts more and more participants. It has become possible due to the telebridges with different Russian regions and foreign countries.

This year the telebridge “Moscow – New York – London – the Russian Federation regions” will take place with the participation of R. Ritch (New York, USA), C. Burgoyne (Portland, USA), C. Tham (Hong Kong, China), K. Martin (Cambridge, UK), S. Migliore (Milan, Italy), K.Leung (Hong Kong, China) and Malyugin B. (Moscow,RF)

Already on the site there is a lecture of Ritch (New York, USA) EXFOLIATION SYNDROME: A NEW FRONTIER CONTROVERSIES IN GLAUCOMA

The Symposium is held by the Russian Academy of Sciences, A.I. Burnazyan Federal Medical and Biophysical Center of the Federal Medical and Biological Agency of the Russian Federation, the Interregional Public Environmental Organization GREENLIGHT, and the Russian Society of Cataract and Refractive Surgeons (RSCRS) with the support of the Helmholtz Association in Russia.



Speakers
Miglior S.
Milan, Italy

Professor, Director of the Ophthalmology Polyclinic of Monza, University of Milano-Bicocca. Professor of Eye Diseases since 2001, has been working in the institutional clinic in Monza, San Gaudenzio clinic in Novara, institutional polyclinic in Verano Brianza, Health Care Center of the polyclinic in Milan, and Columbus Clinic Center in Milan.

During 10 years he was the manager and main researcher of the European Glaucoma Prevention Study and for 8 years he participated in the Europen Hypertension Treatment Study.

President of the Italian Association of Glaucoma Study (AISG).

Leung K.
Hong Kong
More...

Professor, Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong Head, Graduate Division, Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Adjunct Professor, Division of Biomedical Engineering, The Hong Kong University of Science and Technology, Honorary Consultant, Hong Kong Eye Hospital, Honorary Consultant, New Territories East Cluster Ophthalmology Service, Honorary Consultant, Department of Ophthalmology, Caritas Medical Centre

More...

Prof Leung is Section Editor of British Journal of Ophthalmology, Contributing Editor of International Glaucoma Review, Editorial Board Member of Ophthalmic Epidemiology, Translational Vision Science & Technology, and Ocular Surgery News (Asia Pacific Edition), and reviewer of over 30 peer-reviewed scientific journals. His research areas:

  • Application of advanced imaging technologies for early detection and monitoring of glaucoma.
  • Investigation of new laser procedures and surgical devices for lowering the intraocular pressure.
  • Development of new therapies to protect and regenerate retinal ganglion cells in glaucoma and other optic neuropathies.
Less...
Martin K.
London, UK

Professor Martin established the Glaucoma Research Laboratory at the University of Cambridge in 2005, working to develop new treatments for eye disease using stem cells, gene therapy and other techniques. He has published over 50 scientific papers on glaucoma in the last 10 years and won the ARVO Foundation for Eye Research / Carl Camras Translational Research Award 2010 and a Senior Investigator Award from the World Glaucoma Association in 2011. He has served on the Program Committee of the World Glaucoma Congresses 2007 (Singapore), 2009 (Boston) and 2011 (Paris) and is currently on the Program Committees for the European Glaucoma Society Meeting 2012 (Copenhagen) and the Glaucoma Research Society Meeting 2012 (Wuerzburg). He is also the current Co-organiser of the Cambridge Ophthalmological Symposium, a well-known international meeting currently in its 42nd year.

Natalia I. Kurysheva
Moscow, RF

Doctor of Medical Sciences, Professor, Head of the Consultative and Diagnostic Department of the Ophthalmology Center of the Federal Medical and Biological Agency of the Russian Federation, A.I. Burnazyan Federal Medical and Biophysical Center of FMBA, Ophthalmological Department of the Institute of Improvement of Professional Skill of FMBA, member of the editorial board of the Glaucoma National Magazine and the Ophthalmology journal, member of the European Glaucoma Society and the American Academy of Ophthalmology. Author of 280 scientific works, 7 monographs and 7 inventions, supervisor and coordinator of the "Glaucomatous Optic Neuropathy" Federal Targeted Program. She has been an invited speaker of EVER (2014), WorldOphthalmological Congress (2016), APOA congress (2017), WGC (2017), AISG conference (2017), OCT and OCT-angiography congress (2015, 2016) and other international meetings.

More...

The research area: Application of advanced imaging technologies for early detection and monitoring of glaucoma; Investigation of new laser procedures for lowering the intraocular pressure in primary open-angle and angle-closure glaucoma; ocular blood flow, normal tension glaucoma and pseudoexfoliation syndrome.

Less...
Ritch R.
New York, USA

Dr. Robert Ritch is an ophthalmologist in New York, New York and is affiliated with multiple hospitals in the area, including Mount Sinai Beth Israel and New York Eye and Ear Infirmary of Mount Sinai. He received his medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice for more than 20 years. He is one of 47 doctors at Mount Sinai Beth Israel and one of 438 at New York Eye and Ear Infirmary of Mount Sinai who specialize in Ophthalmology. He also speaks multiple languages, including Spanish, Chinese (Mandarin), Tagalog, Korean, Russian, Arabic, Hindi, Portuguese, Hebrew, Japanese, Thai, Chinese (Cantonese) and Urdu.

More...

Dr. Robert Ritch founded the Glaucoma Center at the New York Eye and Ear Infirmary in 1983 to bring increased awareness into the diagnosis and treatment of this common blinding disease.

Changing the way that people understand glaucoma has lead Dr. Robert Ritch to being internationally acclaimed in this field. He continues his unending quest towards finding the cause and cure of glaucoma, and for improving diagnostic and treatment modalities. With the help of more than 20 highly qualified and dedicated personnel in their Manhattan offices, Robert Ritch, MD, LLC continues to lead the way in the diagnosis and management of glaucoma.

Dr. Robert Ritch holds the Shelley and Steven Einhorn Distinguished Chair in Ophthalmology and is Surgeon Director Emeritus and Chief of Glaucoma Services at the New York Eye & Ear Infirmary of Mount Sinai, New York City and Professor of Ophthalmology. He has devoted his career to broadening our understanding of the underlying etiologies and mechanisms of glaucoma and innovation in its medical, laser, and surgical treatment. When still a fellow in 1978, he performed the first laser iridotomy in New York and initiated the first course on laser treatment of glaucoma at the American Academy of Ophthalmology. He developed argon laser peripheral iridoplasty for the treatment of angle closure more complicated than pupillary block, which was instrumental in dealing with angle closure in East Asia, and taught on the diagnosis and treatment of angle closure around the world. His other major interests throughout his career have been pigment dispersion syndrome, exfoliation syndrome, and normal-tension glaucoma, to which he has made seminal contributions. He is a world leader in exfoliation syndrome, which affects 80 million people, and has started a global consortium to work on preventing, reversing, and even curing this disease.

Dr. Ritch has co-authored or edited nine textbooks and over 1800 medical and scientific papers, book chapters, articles and abstracts. He has presented over 750 lectures worldwide, including 50 named lectures and has received over 60 national and international awards and medals.

Dr. Ritch has been President of the Ophthalmic Laser Surgical Society, the New York Glaucoma Society, the Section on Ophthalmology of the New York Academy of Medicine, and the New York Society for Clinical Ophthalmology. He has served on numerous medical and scientific advisory, editorial, and organizational boards including the Helen Keller Foundation, the World Glaucoma Association, and the Board of Directors of the Pan-American Association of Ophthalmology. He was elected to the American Ophthalmological Society, Glaucoma Research Society and Academia Ophthalmologica Internationalis. His appointments include Adjunct Senior Principal Research Scientist at the Singapore Eye Research Institute.

In 2002, he was appointed to the Advisory Committee to the Board of Directors of the International Council of Ophthalmology and was elected Chairman of the Committee in 2009 and appointed to the Board of Directors of the International Council. He was elected to the Board of Trustees of the Association for Research in Vision and Ophthalmology and served as Vice-President in 2006-2007. He was Guest of Honor of the American Glaucoma Society (2013) the Asia-Pacific Glaucoma Congress (2014), and the Italian Ophthalmological Society (2017).

In 1985, he founded the Glaucoma Foundation and has served as Secretary, Medical Director, and Chairman of the Scientific Advisory Board. In 1994, he initiated the annual Optic Nerve Rescue and Regeneration Think Tank, which has attracted numerous successful researchers from other fields into glaucoma research. He also co-founded the New York Glaucoma Research Institute, a not-for-profit foundation to sponsor clinical research in glaucoma, the alt.support.glaucoma Internet newsgroup, the New York Glaucoma Support and Education Group, and the World Glaucoma Patient Association. He was one of the three organizers of the first annual World Glaucoma Day in 2008.

Dr. Ritch has trained over 150 clinical and research fellows, many of whom occupy academic positions worldwide. The international training program that he established at the New York Eye and Ear Infirmary has hosted over 100 International Council of Ophthalmology fellows and more than 140 observers from over 50 countries. He has worked and lectured extensively at the international level throughout his career and has organized many symposia and conferences both in the United States and abroad. He has been organizing chairman, coordinator, or convener for nearly 100 meetings and has served as Convener for the Asia-Pacific Academy of Ophthalmology and the World Ophthalmology Congress several times. He has trained over 80 fellows, ICO fellows, and observers from Asia, helped to establish residency and teaching programs and has made fundamental contributions to the modernization of ophthalmology in Thailand, Malaysia, the Philippines, Laos, Myanmar and other countries in Asia, and in Latin America.

Less...
Tham C.
Hong Kong

S.H. Ho Professor of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, Chairman, Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Director, CUHK Eye Centre, Honorary Consultant, New Territories East Cluster Ophthalmology Service, Vice President and Fellowship Examiner, The College of Ophthalmologists of Hong Kong (COHK), Deputy Director, Joint Shantou International Eye Center, Secretary General & CEO, Asia-Pacific Academy of Ophthalmology (APAO), Vice President, Asia-Pacific Glaucoma Society (APGS), Chair, Academia Ophthalmologica Internationalis (AOI).

Burgoyne C.
Portland, USA

Glaucoma Clinician and Surgeon, Senior Scientist Van Buskirk Chair for Ophthalmic Research, Director, Optic Nerve Head Research Laboratory at the Devers Eye Institute in Portland, Oregon. Clinical Professor of Ophthalmology Oregon Health and Sciences University. He is a member of the Association for Research and Vision in Ophthalmology since 2013. After an undergraduate Bachelor of Arts degree in Architecture and Medical School at the University of Minnesota, he pursued Ophthalmology residency training at the University of Pittsburgh and Glaucoma Fellowship training at the Wilmer Eye Institute at the Johns Hopkins Hospitals in Baltimore, MD.

More...

For twelve years he was Director of Glaucoma Services at the LSU Eye Center in New Orleans before moving to Devers in 2005. For the past 20 years his laboratory has been NIH funded to study the effects of aging and experimental glaucoma on the neural and connective tissues of the monkey optic nerve head within 3D histomorphometric reconstructions. This work now extends to studying the cell biology of connective tissue remodeling and axonal insult early in the disease. Building upon its 3D capabilities, his laboratory is also funded to use Optical Coherence Tomography (OCT) to phenotype the deep tissues of the monkey and human optic nerve head and peripapillary sclera. The author of 7 book chapters and 92 peer reviewed publications. In 2015, Claude Burgoyne was awarded as a clinician-scientist.

Less...
Malyugin B.
Moscow, RF

Professor of Ophthalmology Department of Cataract & Implant Surgery Deputy Director General (R&D, Edu) S.Fyodorov Eye Microsurgery State Institution

More...

Russian Society of Ophthalmologists (RSO), Board Member RSO Cataract and Refractive Surgery Commission, Chief International Intraocular Implant Club, Member ESCRS, Board Member

Ophthalmic Surgery (Russia), Chief Medical Editor The News in Ophthalmology (Russia), Associate Editor EuroTimes (International), Editorial Board Member EuroTimes (Russia), Medical Editor Cataract and Refractive Surgery Today (Europe), Editorial Board Member Ocular Surgery News (Europe & Asia-Pacific), Editorial Board Member Journal of Intraocular Implant & Refractive Society (India), Editorial Board Member Annals of Ophthalmology, Editorial Board Member Eye Care Review, Editorial Board Member

Less...
Miglior S.
Milan, Italy

Professor, Director of the Ophthalmology Polyclinic of Monza, University of Milano-Bicocca. Professor of Eye Diseases since 2001, has been working in the institutional clinic in Monza, San Gaudenzio clinic in Novara, institutional polyclinic in Verano Brianza, Health Care Center of the polyclinic in Milan, and Columbus Clinic Center in Milan.

During 10 years he was the manager and main researcher of the European Glaucoma Prevention Study and for 8 years he participated in the Europen Hypertension Treatment Study.

President of the Italian Association of Glaucoma Study (AISG).

Martin K.
London, UK

Professor Martin established the Glaucoma Research Laboratory at the University of Cambridge in 2005, working to develop new treatments for eye disease using stem cells, gene therapy and other techniques. He has published over 50 scientific papers on glaucoma in the last 10 years and won the ARVO Foundation for Eye Research / Carl Camras Translational Research Award 2010 and a Senior Investigator Award from the World Glaucoma Association in 2011. He has served on the Program Committee of the World Glaucoma Congresses 2007 (Singapore), 2009 (Boston) and 2011 (Paris) and is currently on the Program Committees for the European Glaucoma Society Meeting 2012 (Copenhagen) and the Glaucoma Research Society Meeting 2012 (Wuerzburg). He is also the current Co-organiser of the Cambridge Ophthalmological Symposium, a well-known international meeting currently in its 42nd year.

Leung K.
Hong Kong

Professor, Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong Head, Graduate Division, Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Adjunct Professor, Division of Biomedical Engineering, The Hong Kong University of Science and Technology, Honorary Consultant, Hong Kong Eye Hospital, Honorary Consultant, New Territories East Cluster Ophthalmology Service, Honorary Consultant, Department of Ophthalmology, Caritas Medical Centre

More...

Prof Leung is Section Editor of British Journal of Ophthalmology, Contributing Editor of International Glaucoma Review, Editorial Board Member of Ophthalmic Epidemiology, Translational Vision Science & Technology, and Ocular Surgery News (Asia Pacific Edition), and reviewer of over 30 peer-reviewed scientific journals. His research areas:

  • Application of advanced imaging technologies for early detection and monitoring of glaucoma.
  • Investigation of new laser procedures and surgical devices for lowering the intraocular pressure.
  • Development of new therapies to protect and regenerate retinal ganglion cells in glaucoma and other optic neuropathies.
Less...
Burgoyne C.
Portland, USA

Glaucoma Clinician and Surgeon, Senior Scientist Van Buskirk Chair for Ophthalmic Research, Director, Optic Nerve Head Research Laboratory at the Devers Eye Institute in Portland, Oregon. Clinical Professor of Ophthalmology Oregon Health and Sciences University. He is a member of the Association for Research and Vision in Ophthalmology since 2013. After an undergraduate Bachelor of Arts degree in Architecture and Medical School at the University of Minnesota, he pursued Ophthalmology residency training at the University of Pittsburgh and Glaucoma Fellowship training at the Wilmer Eye Institute at the Johns Hopkins Hospitals in Baltimore, MD.

More...

For twelve years he was Director of Glaucoma Services at the LSU Eye Center in New Orleans before moving to Devers in 2005. For the past 20 years his laboratory has been NIH funded to study the effects of aging and experimental glaucoma on the neural and connective tissues of the monkey optic nerve head within 3D histomorphometric reconstructions. This work now extends to studying the cell biology of connective tissue remodeling and axonal insult early in the disease. Building upon its 3D capabilities, his laboratory is also funded to use Optical Coherence Tomography (OCT) to phenotype the deep tissues of the monkey and human optic nerve head and peripapillary sclera. The author of 7 book chapters and 92 peer reviewed publications. In 2015, Claude Burgoyne was awarded as a clinician-scientist.

Less...
Natalia I. Kurysheva
Moscow, RF

Doctor of Medical Sciences, Professor, Head of the Consultative and Diagnostic Department of the Ophthalmology Center of the Federal Medical and Biological Agency of the Russian Federation, A.I. Burnazyan Federal Medical and Biophysical Center of FMBA, Ophthalmological Department of the Institute of Improvement of Professional Skill of FMBA, member of the editorial board of the Glaucoma National Magazine and the Ophthalmology journal, member of the European Glaucoma Society and the American Academy of Ophthalmology. Author of 280 scientific works, 7 monographs and 7 inventions, supervisor and coordinator of the "Glaucomatous Optic Neuropathy" Federal Targeted Program. She has been an invited speaker of EVER (2014), WorldOphthalmological Congress (2016), APOA congress (2017), WGC (2017), AISG conference (2017), OCT and OCT-angiography congress (2015, 2016) and other international meetings.

More...

The research area: Application of advanced imaging technologies for early detection and monitoring of glaucoma; Investigation of new laser procedures for lowering the intraocular pressure in primary open-angle and angle-closure glaucoma; ocular blood flow, normal tension glaucoma and pseudoexfoliation syndrome.

Less...
Ritch R.
New York, USA

Dr. Robert Ritch is an ophthalmologist in New York, New York and is affiliated with multiple hospitals in the area, including Mount Sinai Beth Israel and New York Eye and Ear Infirmary of Mount Sinai. He received his medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice for more than 20 years. He is one of 47 doctors at Mount Sinai Beth Israel and one of 438 at New York Eye and Ear Infirmary of Mount Sinai who specialize in Ophthalmology. He also speaks multiple languages, including Spanish, Chinese (Mandarin), Tagalog, Korean, Russian, Arabic, Hindi, Portuguese, Hebrew, Japanese, Thai, Chinese (Cantonese) and Urdu.

More...

Dr. Robert Ritch founded the Glaucoma Center at the New York Eye and Ear Infirmary in 1983 to bring increased awareness into the diagnosis and treatment of this common blinding disease.

Changing the way that people understand glaucoma has lead Dr. Robert Ritch to being internationally acclaimed in this field. He continues his unending quest towards finding the cause and cure of glaucoma, and for improving diagnostic and treatment modalities. With the help of more than 20 highly qualified and dedicated personnel in their Manhattan offices, Robert Ritch, MD, LLC continues to lead the way in the diagnosis and management of glaucoma.

Dr. Robert Ritch holds the Shelley and Steven Einhorn Distinguished Chair in Ophthalmology and is Surgeon Director Emeritus and Chief of Glaucoma Services at the New York Eye & Ear Infirmary of Mount Sinai, New York City and Professor of Ophthalmology. He has devoted his career to broadening our understanding of the underlying etiologies and mechanisms of glaucoma and innovation in its medical, laser, and surgical treatment. When still a fellow in 1978, he performed the first laser iridotomy in New York and initiated the first course on laser treatment of glaucoma at the American Academy of Ophthalmology. He developed argon laser peripheral iridoplasty for the treatment of angle closure more complicated than pupillary block, which was instrumental in dealing with angle closure in East Asia, and taught on the diagnosis and treatment of angle closure around the world. His other major interests throughout his career have been pigment dispersion syndrome, exfoliation syndrome, and normal-tension glaucoma, to which he has made seminal contributions. He is a world leader in exfoliation syndrome, which affects 80 million people, and has started a global consortium to work on preventing, reversing, and even curing this disease.

Dr. Ritch has co-authored or edited nine textbooks and over 1800 medical and scientific papers, book chapters, articles and abstracts. He has presented over 750 lectures worldwide, including 50 named lectures and has received over 60 national and international awards and medals.

Dr. Ritch has been President of the Ophthalmic Laser Surgical Society, the New York Glaucoma Society, the Section on Ophthalmology of the New York Academy of Medicine, and the New York Society for Clinical Ophthalmology. He has served on numerous medical and scientific advisory, editorial, and organizational boards including the Helen Keller Foundation, the World Glaucoma Association, and the Board of Directors of the Pan-American Association of Ophthalmology. He was elected to the American Ophthalmological Society, Glaucoma Research Society and Academia Ophthalmologica Internationalis. His appointments include Adjunct Senior Principal Research Scientist at the Singapore Eye Research Institute.

In 2002, he was appointed to the Advisory Committee to the Board of Directors of the International Council of Ophthalmology and was elected Chairman of the Committee in 2009 and appointed to the Board of Directors of the International Council. He was elected to the Board of Trustees of the Association for Research in Vision and Ophthalmology and served as Vice-President in 2006-2007. He was Guest of Honor of the American Glaucoma Society (2013) the Asia-Pacific Glaucoma Congress (2014), and the Italian Ophthalmological Society (2017).

In 1985, he founded the Glaucoma Foundation and has served as Secretary, Medical Director, and Chairman of the Scientific Advisory Board. In 1994, he initiated the annual Optic Nerve Rescue and Regeneration Think Tank, which has attracted numerous successful researchers from other fields into glaucoma research. He also co-founded the New York Glaucoma Research Institute, a not-for-profit foundation to sponsor clinical research in glaucoma, the alt.support.glaucoma Internet newsgroup, the New York Glaucoma Support and Education Group, and the World Glaucoma Patient Association. He was one of the three organizers of the first annual World Glaucoma Day in 2008.

Dr. Ritch has trained over 150 clinical and research fellows, many of whom occupy academic positions worldwide. The international training program that he established at the New York Eye and Ear Infirmary has hosted over 100 International Council of Ophthalmology fellows and more than 140 observers from over 50 countries. He has worked and lectured extensively at the international level throughout his career and has organized many symposia and conferences both in the United States and abroad. He has been organizing chairman, coordinator, or convener for nearly 100 meetings and has served as Convener for the Asia-Pacific Academy of Ophthalmology and the World Ophthalmology Congress several times. He has trained over 80 fellows, ICO fellows, and observers from Asia, helped to establish residency and teaching programs and has made fundamental contributions to the modernization of ophthalmology in Thailand, Malaysia, the Philippines, Laos, Myanmar and other countries in Asia, and in Latin America.

Less...
Tham C.
Hong Kong

S.H. Ho Professor of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, Chairman, Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Director, CUHK Eye Centre, Honorary Consultant, New Territories East Cluster Ophthalmology Service, Vice President and Fellowship Examiner, The College of Ophthalmologists of Hong Kong (COHK), Deputy Director, Joint Shantou International Eye Center, Secretary General & CEO, Asia-Pacific Academy of Ophthalmology (APAO), Vice President, Asia-Pacific Glaucoma Society (APGS), Chair, Academia Ophthalmologica Internationalis (AOI).

Malyugin B.
Moscow, RF

Professor of Ophthalmology Department of Cataract & Implant Surgery Deputy Director General (R&D, Edu) S.Fyodorov Eye Microsurgery State Institution

Russian Society of Ophthalmologists (RSO), Board Member RSO Cataract and Refractive Surgery Commission, Chief International Intraocular Implant Club, Member ESCRS, Board Member

Ophthalmic Surgery (Russia), Chief Medical Editor The News in Ophthalmology (Russia), Associate Editor EuroTimes (International), Editorial Board Member EuroTimes (Russia), Medical Editor Cataract and Refractive Surgery Today (Europe), Editorial Board Member Ocular Surgery News (Europe & Asia-Pacific), Editorial Board Member Journal of Intraocular Implant & Refractive Society (India), Editorial Board Member Annals of Ophthalmology, Editorial Board Member Eye Care Review, Editorial Board Member

Less...
Reports
EXFOLIATION SYNDROME: A NEW FRONTIER CONTROVERSIES IN GLAUCOMA
Ritch R., New York, USA

The lecture covers the history of pseudoexfoliation (PES) discovery, its epidemiology and clinical appearance. The main attention is focused on the pathogenesis including genetics, autophagy, lysosomes, mitochondrial and microtubules dysfunction. The author emphasizes how the recent discoveries in the pathogenesis of PES may change its treatment in the nearest future. Underlying the common features with other disorders, professor Ritch names PES as their ocular manifestation. Thereby in his lecture he discusses the non-IOP- lowering treatment.

Program
November 17, 2017
12.00 - 18.30
12.00 - 13.00
Registration of the Symposium Participants
13.00 - 13.10
Welcome speeches

The introduction and greetings from FMBA of the Russian Federeation (Samoilov A.S.), RSCRS (Trubilin V.) and the Helmholtz-Centre Potsdam – GFZ German Research Centre for Geosciences (Helmholtz Association) (Eremenko E.)

13.10 - 13.15
Introduction of the speakers
Kurysheva N. (Moscow)
13.15 - 13.40
The main discoveries in glaucoma field and the results of the multicenter studies
Miglior S. (Milan)
13.40 - 14.00
Glaucoma diagnostics and detection of its progression. What is in the future?
Leung K. (Hong Kong)
14.00 - 14.20
Neuroprotection and neuroregeneration in glaucoma
Martin K. (London)
14.20 - 14.45
Pseudoexfoliation and glaucoma: the recent discoveries and how they will influence the glaucoma treatment
Ritch R. (New York)
14.45 - 15.00
Demonstration and discussion of clinical case
Ritch R., Silva L. (New York)
15.05 - 15.30
Discussion
Ritch R., Silva L.

Tele-bridge with the New York Eye and Ear Infirmary of Mount Sinai

15.30 - 15.45
What are the perspectives of the treatment of retinal ganglion cells in glaucoma? Where are we now? Discussion
Martin K. (London)

Tele-bridge with the Cambridge Centre for Brain Repair, University of Cambridge

15.45 - 16.00
Discussion
Ritch R., Silva L.

Tele-bridge with the New York Eye and Ear Infirmary of Mount Sinai

16.00 - 16.20
coffee break
16.20 - 16.40
Angle Closure Management A Logical Approach Based on Angle Closure Type and Mechanisms
Tham C. (Hog Kong)
16.40 - 17.00
Conceptual, research and clinical advances of importance in glaucoma – a personal opinion
Burgoyne C. (Portland)
17.00 - 17.30
The perspectives of laser and medical glaucoma treatment
Kurysheva N. (Moscow)
17.30 - 17.50
Current trends of glaucoma microsurgery in patients with cataract
Malyugin B. (Moscow)
17.50 - 18.10
The perspectives of surgical glaucoma treatment
Miglior S. (Milan)
18.10 - 18.30
Discussion with the regions of the Russian Federation and closing remarks
PARTNERS
VI INTERNATIONAL SYMPOSIUM
DATE AND VENUE
November 17, 2017, 13.00 - 18.20 Congress Center, I.M. Sechenov First Moscow State Medical University
8, Trubetskaya st., Moscow
Смотреть схему проезда